| 中文名称 | (±)-氯丁醇钠盐 |
|---|---|
| 中文别名 | 氯前列醇钠;氯前列烯醇钠;7-[2-[4-(3-氯苯氧基)-3-羟基丁-1-烯基]-3,5-二羟基环戊基]庚-5-烯酸钠;氯比前列腺素钠;前列烯醇钠;氯前列醇钠(D型);氯前列醇钠(DL型);DL-氯前列醇钠;(±)-氯前列醇钠;DL-氯前列醇钠盐;反式-4-乙基环己烷甲酸;氯前列醇钠 API;氯前列醇钠标准品;氯前列烯醇钠 USP标准品;(+/-)-氯前列醇钠盐水合物 |
| 英文名称 | Cloprostenol sodium salt |
| 英文别名 | (+)-cloprostenol sodium;15-EPI CLOPROSTENOL;15(S)-CLOPROSTENOL;16-(3-CHLOROPHENOXY)-9,11,15R-TRIHYDROXY-17,18,19,20-TETRANORPROSTA-5Z,13E-DIEN-1-OIC ACID SODIUM SALT;(+)-16-M-CHLOROPHENOXY TETRANOR PROSTAGLANDIN F2ALPHA SODIUM SALT;16-(M-CHLOROPHENOXY)-TETRANOR-PROSTAGLANDIN-F2ALPHA, SODIUM SALT;(+/-)-9ALPHA,11ALPHA,15-TRIHYDROXY-16-(3-CHLOROPHENOXY)-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID, SODIUM SALT;(+/-)-9ALPHA,11ALPHA,15S-TRIHYDROXY-16-(3-CHLOROPHENOXY)-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID;(+)-9ALPHA,11ALPHA,15R-TRIHYDROXY-16-(3-CHLOROPHENOXY)-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID, SODIUM SALT;(5Z)-rel-Cloprostenol Sodium;(+/-)-Cloprostenol sodium salt hydrate;(±)-Cloprostenol sodium;(±)-Cloprostenol sodium salt;Cloprostenol (sodium salt);Cloprostenol Sodium;Cloprostenol sodium salt;Sodium [1alpha(Z),2beta(1E,3R*),3alpha,5alpha]-(+/-)-7-[2-[4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate;Estrumate;(+/-)-Cloprostenol sodium salt;81129I41BJ;ICI 80996;Estroplan;C22H28ClNaO6;(+)-CLOPROSTENOL SODIUM SALT;Cloprostenol sodium [USAN:USP];Sodium (Z)-7-((1R,2R,3R,5S)-2-((R,E)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate;CLOPROSTENOL Na;D-Cloprostenol sodium salt;Cloprostenol sodium, (+)-;DSSTox_RID_81;UNII-886SAV9675;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, monosodium salt, (5Z)-rel-;Tox21_112261;CLOPROSTENOL SODIUM (USP-RS);HMS3268J10;AC-25916;ICI-80996;MLS000028831;HMS3413C18;Cloprostenol sodium [USAN];CLOPROSTENOL SODIUM [USP-RS];CAS-55028-72-3;MFCD05863539;AKOS024457034;Estrumate, Heifex;Sodium (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-(1)-7-(2-(4-(3-chlorophenoxy)-3-hydroxybut-1-enyl)-3,5-dihydroxycyclopentyl)hept-5-enoate;CLOPROSTENOL SODIUM (USP IMPURITY);EX-A1351;CLOPROSTENOL SODIUM [USP MONOGRAPH];CLOPROSTENOL SODIUM [USP IMPURITY];62561-03-9;NCGC00165774-02;AC-6102;UNII-81129I41BJ;5-HEPTENOIC ACID, 7-(2-(4-(3-CHLOROPHENOXY)-3-HYDROXY-1-BUTENYL)-3,5-DIHYDROXYCYCLOPENTYL)-, (1A(Z),2B(1E,3R*),3.ALPHA.,5.ALPHA.)-, SODIUM SALT, (+/-)-;NCGC00159550-01;AT39750;16-(m-Chlorophenoxy)-tetranor- prostaglandin F2alpha,sodium salt;5-Heptenoic acid, 7-((1R,2R,3R,5S)-2-((1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl)-3,5-dihydroxycyclopentyl)-, sodium salt (1:1), (5Z)-;J-524252;886SAV9675;(+)-Cloprostenol (sodium salt);SCHEMBL28242;D-Cloprostenol sodium;5-Heptenoic acid, 7-(2-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-, (1alpha(Z),2beta(1E,3R*),3alpha,5alpha)-, sodium salt, (+-)-;CLOPROSTENOL SODIUM (USP MONOGRAPH);Cloprostenol Monosodium Salt;estroPLAN Injection;DTXSID1046500;AMY30120;(+-)-Sodium (Z)-7-((1R*,2R*,3R*,5S*)-2-((E)-(3R*)-4-(m-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate;AKOS015967190;sodium;... |
| CAS No. | 55028-72-3 |
| 分子式 | C22H28ClNaO6 |
| 分子量 | 446.90 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学